Tag: GRPN

Blue Horseshoe Stocks: BTCS Recap, EVOK & More

BTCS, Inc. BTCS

We caught BTCS on a routine scan yesterday morning after noticing some abnormal activity from the session prior. Our timing ended up being extremely fortuitous, with the stock making quite an impressive morning run.

From a low of .0013, it surged up as high as .0024 just prior to midday, for a healthy pop of 85% on almost ten times the three-month average volume. If BTCS can hold support at or above yesterday’s swing low, we’ll continue to be interested in the possibilities it may provide.

Evoke Pharma, Inc. EVOK

EVOK is another fresh play that we’re taking a look at for the first time this morning. The stock has recently fallen off of a cliff, as we’ve pointed out on the annotated chart below. Beginning with a massive gap-down earlier this month, followed by several sessions of backsliding which culminated in a new 52-week low (1.52) being set on Monday.

Yesterday’s bottom-bounce activity is what has us on alert. The stock is heavily oversold, and could be in line for a substantial rebound. We’ll want to be hanging around when that occurs, because even a return to the bottom of the chart gap at 3.50, from current levels, would spell an opportunity for significant gains.

Tempur Sealy International, Inc. TPX – Options Idea

TPX is fresh off an earnings beat this morning which has it gapping up into the $70-range. We’re going to signal a range of longer-term options ideas for us to track in the days and weeks to come. Our area of interest here is going to be the TPX 08/19 $70-80 Calls, giving us just over three weeks’ time to see a continued PPS recovery. 

Extended Watchlist:
SOULD, GYST, GRPN, EBIO, EPRS, WEYL
 NSRS(Potential Bottom Bouncer)

Blue Horseshoe Stocks: Options Roundup & More

Options Roundup

We produced three sets of options ideas in yesterday morning’s premarket report, and considering our recent track record with options plays, it should come as no surprise that we hit on some big gainers with all of them.

Petroleo Brasiliero SA (Petrobras) PBR

We’ve successfully come up with winning options ideas for PBR on so many occasions, we’ve lost count at this point. Our targeted contracts yesterday were the Weekly $5 and $5.50 Calls, and both sets recorded solid moves on the day.

For the $5’s we saw a nice run from .42-.77, an intraday swing of 83%, while the $5.50 Calls doubled that performance with a 166% pop from .12-.32. 

We mentioned that the idea could serve for swing trades into today, and it appears as if PBR’s gap up will extend the gains we’ve seen thus far, especially considering that oil is presently at its highest price in months. In addition to staying on top of those 5.50’s, we’ll explore the possibility of rolling up our strike price to the 6.00-level. We’ll just need to see the stock hold support at its previous resistance point of 5.72 on any early pullbacks.

__________

United Parcel Service, Inc. UPS

The next idea we came up with was to take a look at UPS April 8th $104 Calls, which we found attractive for a number of reasons that we listed in our report, and those contracts put up a top-notch performance as well.

They started out from a low of .47 and would end up hitting a daily high of 1.50; gains of up to 219% were there for the taking.

__________

SeaWorld Entertainment, Inc. SEAS

We were very interested in Seaworld’s PR concerning the halting of the Killer Whale breeding programs and theater show phase-out yesterday(>>View PR). The announcement was received well by the investing community, as well as the company seeing goodwill on social media for doing the right thing- at one point on Twitter, #Seaworld was trending in the Top 3 for the US in the wake of the news.

We set our sights on SEAS April 15th $18 Calls, and were met with an excellent intraday gain opportunity as they ran 150% from .40-1.00.

Sparta Commercial Services, Inc. SRCO

We also want to give ourselves a pat on the back for SRCO, which we included in yesterday’s extended watchlist. The stock made a respectable intraday move for us, to the tune of 60% as it traded in a range from .003-.0048 on roughly six times the 3-month average volume.

Bank of America Corp. BAC – Fresh Options Idea

BAC is currently gapping up in the premarket on news that the company will be increasing the scope of their share buyback program, and we’re going to signal a set of options contracts for observation to correspond with that. We’re going to be taking a look at BAC Weekly $13.50 Calls for a possible daytrade*.

*Don’t forget, trading weekly options contracts on a Friday is a very risky proposition, and is recommended for seasoned traders only.

Extended Watchlist:
DNR, CHK, WLL, XCO, GRPN, GDPM, LEGX, COTE(Possible bottom bouncer)

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Solaris Power Cells, Inc. SPCL

We’ve got a news play hitting our scanner this morning in SPCL, and as it turns out, the chart is looking ripe for a nice move. As we’ve pointed out on the following snapshot, the stock is trading near a relative bottom, having just registered a new 52-week low just two weeks ago.

Our regular readers are well acquainted with our history of banking excellent gains off a good rebound play. SPCL could be next in line on that front, so we’ll keep a sharp eye on it to start the week.

In addition to trading near a bottom, we’re seeing signs of a very oversold stock with a lot of room to the upside:

PALM SPRINGS, Calif., July 13, 2015 (GLOBE NEWSWIRE) — Solaris Power Cells, Inc. the creators of the Solaris PESATM “Passive Electron Storage Array”™, (the “Company”) (OTCQB:SPCL)  the Board of Directors of Solaris Power Cells today announced the appointment of long-time energy policy leader Robert Foster to lead Solaris Energy Storage Advisory Board, effective July 10th 2015. >> FULL PR

OncoGenex Pharmaceuticals, Inc OGXI

OGXI announced this morning that one of its cancer treatments, currently in Phase III trials has passed rigorous criteria and
that trials for patients with non-small cell lung cancer will proceed as planned. The stock is gapping up in premarket trading, and we’re going to monitor its activity as the session commences.

BOTHELL, Wash. and VANCOUVER, British Columbia, July 13, 2015 /PRNewswire/ — OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee>> FULL PR


Frontline, Ltd. FRO

We’ve got a long history with FRO that stretches all the way back to 2012. We tagged FRO in Thursday’s premarket report, after it hit a relative bottom of 2.21 on Wednesday. Our observed low following Thursday’s alert was 2.32, and on Friday we saw as the stock inched up to a high of 2.43. We’re going to be on the lookout for further gains; the stock is gapping up slightly in early trading this morning.

An added element to the story is an opinion article that came across the wires last week pertaining to the perceived undervaluation of FRO. It points to a potential longer-term uptrend in the cards, stating that while this year’s earnings growth is expected to top last year’s by more than 200%, that hasn’t really been reflected in the share price. We suggest our subscribers click the following link and give it a read >> VIEW ARTICLE

Extended Watchlist:
PSDV, GILT, FREE, GRPN, DANG, CLTX, DRYS